T. J. Crijns, D. Ring, Department of Surgery and Perioperative Care, Dell Medical School, the University of Texas at Austin, Austin, TX, USA.
D. N. Bernstein, R. Gonzalez, D. Wilbur, Department of Orthopaedics and Rehabilitation, University of Rochester Medical Center, University of Rochester, Rochester, NY, USA.
Clin Orthop Relat Res. 2020 Jun;478(6):1319-1329. doi: 10.1097/CORR.0000000000001170.
Depression symptoms are prevalent in the general population, and as many as one in eight patients seeing a hand surgeon may have undiagnosed major depression. It is not clear to what degree lower mood is the consequence or cause of greater symptoms and limitations. If depressive symptoms are a consequence of functional limitations, they might be expected to improve when pathophysiology and impairment are ameliorated. Because surgical treatment is often disease-modifying or salvage, surgery might have a greater impact than nonoperative treatment, which is more often palliative (symptom relieving) than disease-modifying.
QUESTIONS/PURPOSES: (1) For which hand or wrist conditions are depression symptoms lower after operative compared with nonoperative treatment? (2) Among the subset of patients with the highest depression scores, are depression symptoms lower after operative treatment compared with nonoperative treatment? (3) Among the subset of patients who had nonoperative treatment, are depression symptoms lower after a corticosteroid injection compared with no specific biomedical intervention?
At an academic orthopaedic department, 4452 patients had a new office visit for carpal tunnel syndrome, benign neoplasm, primary hand osteoarthritis, de Quervain's tendinopathy, or trigger digit. We analyzed the 1652 patients (37%) who had a return visit at least 3 months later for the same diagnosis. Patients completed the Patient-reported Outcomes Measurement Information System (PROMIS) Depression computerized adaptive test at every office visit (higher scores indicate more depression symptoms) and PROMIS Pain Interference (higher scores indicates greater hindrance in daily life owing to pain). Patients with a return visit were more likely to have surgical treatment and had greater Pain Interference scores at the first visit. Thirteen percent of patients (221 of 1652) had incomplete or missing scores at the initial visit and 33% (550 of 1652) had incomplete or missing scores at the final return visit. We used multiple imputations to account for missing or incomplete data (imputations = 50). In a multivariable linear regression analysis, we compared the mean change in Depression scores between patients treated operatively and those treated nonoperatively, accounting for PROMIS Pain Interference scores at the first visit, age, gender diagnosis, provider, and treatment duration. A post-hoc power analysis demonstrated that the smallest patient cohort (benign lump, n = 176) provided 99% power (α = 0.05) with eight predictor variables to detect a change of 2 points in the PROMIS Depression score (minimally important difference = 3.5).
After controlling for potentially confounding variables such as pain interference and age, only carpal tunnel release was associated with a slightly greater decrease in depression symptoms compared with nonoperative treatment (regression coefficient [RC] = -3 [95% confidence interval -6 to -1]; p = 0.006). In patients with the highest PROMIS Depression scores for each diagnosis, operative treatment was not associated with an improvement in depression symptoms (carpal tunnel release: RC = 5 [95% CI -7 to 16]; p = 0.44). Moreover, a corticosteroid injection was not associated with fewer depression symptoms than no biomedical treatment (carpal tunnel release: RC = -3 [95% CI -8 to 3]; p = 0.36).
Given that operative treatment of hand pathology is not generally associated with a decrease in depression symptoms, our results support treating comorbid depression as a separate illness rather than as a secondary effect of pain or physical limitations.
Level II, therapeutic study.
抑郁症状在普通人群中很常见,每 8 名看手外科医生的患者中就可能有 1 名患有未确诊的重度抑郁症。目前尚不清楚情绪低落在多大程度上是症状和功能障碍的结果或原因。如果抑郁症状是功能障碍的结果,那么当病理生理学和损伤得到改善时,它们可能会得到改善。由于手术治疗通常是疾病修正或挽救性的,因此手术可能比非手术治疗的影响更大,而非手术治疗往往更多是缓解症状而不是修正疾病。
问题/目的:(1)对于哪些手部或腕部疾病,手术治疗后抑郁症状比非手术治疗后更低?(2)在抑郁评分最高的患者亚组中,手术治疗后抑郁症状是否比非手术治疗后更低?(3)在接受非手术治疗的患者亚组中,皮质类固醇注射后抑郁症状是否比没有特定生物医学干预的情况下更低?
在一家学术骨科系,4452 名患者因腕管综合征、良性肿瘤、原发性手部骨关节炎、De Quervain 腱鞘炎或扳机指而首次就诊。我们分析了在至少 3 个月后因相同诊断再次就诊的 1652 名患者(37%)。患者在每次就诊时都完成了患者报告的结果测量信息系统(PROMIS)抑郁计算机自适应测试(得分越高表示抑郁症状越严重)和 PROMIS 疼痛干扰(得分越高表示疼痛对日常生活的干扰越大)。有复诊的患者更有可能接受手术治疗,并且在首次就诊时疼痛干扰评分更高。13%的患者(221/1652)初始就诊时存在不完整或缺失的评分,33%(550/1652)在最终复诊时存在不完整或缺失的评分。我们使用多重插补来处理缺失或不完整的数据(插补=50)。在多变量线性回归分析中,我们比较了手术治疗和非手术治疗患者之间抑郁评分的平均变化,同时考虑了首次就诊时的 PROMIS 疼痛干扰评分、年龄、性别诊断、治疗提供者和治疗持续时间。事后的功效分析表明,最小患者队列(良性肿块,n=176)在 8 个预测变量下提供了 99%的功效(α=0.05),以检测 PROMIS 抑郁评分变化 2 分(最小有意义差异=3.5)。
在控制了潜在的混杂变量,如疼痛干扰和年龄后,只有腕管松解术与非手术治疗相比,抑郁症状略有改善(回归系数[RC]=-3[95%置信区间-6 至-1];p=0.006)。在每个诊断的 PROMIS 抑郁评分最高的患者亚组中,手术治疗与抑郁症状的改善无关(腕管松解术:RC=5[95%CI-7 至 16];p=0.44)。此外,皮质类固醇注射与无生物医学治疗相比,并没有更少的抑郁症状(腕管松解术:RC=-3[95%CI-8 至 3];p=0.36)。
鉴于手部病理的手术治疗通常不会导致抑郁症状的减轻,我们的结果支持将共病性抑郁作为一种单独的疾病来治疗,而不是将其作为疼痛或身体功能障碍的次要影响。
II 级,治疗性研究。